-
Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab
Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.
Sep 28, 2023
-
Follow the Money: NCI Awards Grant For Prostate Cancer Treatment Study, Recruiting Participants For Immunotherapy Drug Trials
Clinical Research News | The Icahn School of Medicine at Mount Sinai nets a grant to identify the best prostate cancer treatment for people with HIV; EverImmune will conduct a phase I/II clinical trial for its drug candidate Oncobax AK in patients undergoing immunotherapy; NIH establishes the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; more.
Sep 27, 2023
-
Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer
Clinical Research News | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.
Sep 26, 2023
-
Adopting New Patient-Centric Payment Solutions for Whole-Industry Benefits
Clinical Research News | The clinical trial landscape has a long-acknowledged problem – a lack of participant diversity. Most clinical trial participants are from higher-income households, white and male.
Sep 22, 2023
